Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 8/20 | 0.57 |
| ▸ | OPRM1 | P35372 | 5/20 | 0.57 |
| ▸ | OPRK1 | P41145 | 5/20 | 0.57 |
| ▸ | AKR1C1 | Q04828 | 1/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.50 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1041473 | 0.97 | OPRL1 (0.55) | OPRL1OPRM1OPRK1AKR1C1OPRD1 | |
| SCHEMBL16469256 | 0.97 | OPRL1 (0.55) | OPRL1OPRM1OPRK1AKR1C1OPRD1 | |
| SCHEMBL29195226 | 0.97 | OPRL1 (0.55) | OPRL1OPRM1OPRK1AKR1C1OPRD1 | |
| SCHEMBL60129 | 0.97 | OPRL1 (0.55) | OPRL1OPRM1OPRK1AKR1C1OPRD1 | |
| SCHEMBL1040024 | 0.97 | OPRL1 (0.55) | OPRL1OPRM1OPRK1AKR1C1OPRD1 | |
| SCHEMBL4556223 | 0.97 | OPRL1 (0.55) | OPRL1OPRM1OPRK1AKR1C1OPRD1 | |
| Hydrogen Peroxide SCHEMBL14842577 | 0.97 | OPRL1 (0.55) | OPRL1OPRM1OPRK1AKR1C1OPRD1 | |
| SCHEMBL1724862 | 0.95 | OPRL1 (0.57) | OPRL1OPRM1OPRK1AKR1C1OPRD1 | |
| Ammonia Solution, Strong SCHEMBL29195223 | 0.92 | OPRL1 (0.55) | OPRL1OPRM1OPRK1AKR1C1OPRD1 | |
| SCHEMBL10060840 | 0.89 | OPRL1 (0.68) | OPRL1OPRM1OPRK1OPRD1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118666674-A | Preparation method of ArF photoresist monomer 2-methyl-1-phenylcyclopentyl ester-2-acrylic acid | 成都东凯芯半导体材料有限公司 | 2024-09-20 | — | — | CN | claimed |
| CN-107896992-A | Cliff chrysanthemum method for tissue culture | 金华市铁骑士生物科技有限公司 | 2018-04-13 | — | — | CN | claimed |
| CN-122071411-A | Method for forming ester by oxidizing and breaking carbon-carbon bond by tertiary alcohol | 中国科学院大连化学物理研究所 | 2026-05-22 | — | — | CN | disclosed |
| EP-4728019-A1 | A MICROWAVE CARBONIZATION ASSEMBLY AND METHOD FOR EXTRACTING COMPONENTS FROM RUBBER | Sable Rubber IP Pty Limited (AU) | 2026-04-22 | — | — | EP | disclosed |
| WO-2024257019-A1 | A MICROWAVE CARBONIZATION ASSEMBLY AND METHOD FOR EXTRACTING COMPONENTS FROM RUBBER | Molectra Rubber IP Pty Ltd (AU) | 2024-12-19 | — | — | WO | disclosed |
| CN-118666674-A | Preparation method of ArF photoresist monomer 2-methyl-1-phenylcyclopentyl ester-2-acrylic acid | 成都东凯芯半导体材料有限公司 | 2024-09-20 | — | — | CN | disclosed |
| CN-117700455-A | Carbon-phosphorus (C-P) coupling reactions involving alkylsilyl peroxides | 广东工业大学 | 2024-03-15 | — | — | CN | disclosed |
| US-20230145003-A1 | COMPOUNDS AND USES THEREOF | FOGHORN THERAPEUTICS INC. | 2023-05-11 | — | — | US | disclosed |
| CN-110218227-B | Method for preparing aryl ketone derivative | 苏州大学 | 2021-12-10 | — | — | CN | disclosed |
| WO-2020191252-A1 | TECHNOLOGIES USEFUL FOR OLIGONUCLEOTIDE PREPARATION | WAVE LIFE SCIENCES LTD. (SG) | 2020-09-24 | — | — | WO | disclosed |
| CN-110218227-A | A method of preparing aryl ketone derivatives | 苏州大学 | 2019-09-10 | — | — | CN | disclosed |
| US-6245804-B1 | CONTRACEPTIVES; UROGENITAL DISORDERS | SCHERING AKTIENGESELLSCHAFT (DE) | 2001-06-12 | — | — | US | disclosed |
| US-6130217-A | ANTITUMOR | PFIZER INC (US) | 2000-10-10 | — | — | US | disclosed |
| WO-2000042045-A2 | FUNCTIONALIZED HETEROCYCLES AS CHEMOKINE RECEPTOR MODULATORS | WARNER-LAMBERT COMPANY (US) | 2000-07-20 | — | — | WO | disclosed |
| CN-1258286-A | Non-steroidal (hetero) cyclically substd. acylanilides with mixed gestagen and androgen activity | SCHERING AG (DE) | 2000-06-28 | — | — | CN | disclosed |
| EP-0986545-A1 | NON-STEROIDAL (HETERO) CYCLICALLY SUBSTITUTED ACYLANILIDES WITH MIXED GESTAGEN AND ANDROGEN ACTIVITY | SCHERING AKTIENGESELLSCHAFT (DE) | 2000-03-22 | — | — | EP | disclosed |
| WO-1998054159-A1 | NON-STEROIDAL (HETERO) CYCLICALLY SUBSTITUTED ACYLANILIDES WITH MIXED GESTAGEN AND ANDROGEN ACTIVITY | SCHERING AKTIENGESELLSCHAFT (DE) | 1998-12-03 | — | — | WO | disclosed |
| WO-1994022846-A1 | COMPOUNDS ENHANCING ANTITUMOR ACTIVITY OF OTHER CYTOTOXIC AGENTS | PFIZER INC. (US) | 1994-10-13 | — | — | WO | disclosed |
| US-4111917-A | POLYURETHANES | W. R. GRACE & CO. (US) | 1978-09-05 | — | — | US | disclosed |
| US-4059640-A | Transalkylation of tertiary amines and alcohols, to produce ethylene glycol | NATIONAL DISTILLERS AND CHEMICAL CORP. (US) | 1977-11-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230145003-A1 | COMPOUNDS AND USES THEREOF | VHL, CLN6, TFEB | OPRL1 4519/4885OPRM1 4702/4885OPRK1 4547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.